Cargando…

Humoral response to vaccination against SARS-CoV-2 in patients undergoing maintenance hemodialysis

Detalles Bibliográficos
Autores principales:	Delgado Ureña, Ana, Hernández García, Elena, Varillas Caso, Dora Angélica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039697/ https://www.ncbi.nlm.nih.gov/pubmed/37033198 http://dx.doi.org/10.1016/j.medcle.2022.11.009

Ejemplares similares

Respuesta humoral a la vacunación frente al SARS-CoV-2 en pacientes sometidos a hemodiálisis de mantenimiento
por: Delgado Ureña, Ana, et al.
Publicado: (2023)

Humoral response to COVID-19 vaccination and maintenance hemodialysis: Correspondence
por: Mungmunpuntipantip, Rujititka, et al.
Publicado: (2023)

Humoral Immune Response to BBV152 (Covaxin) SARS-CoV-2 Vaccine in Patients on Hemodialysis
por: Vijayaraghavan, Radha, et al.
Publicado: (2023)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

Humoral responses to BNT162b2 SARS-CoV-2 and hepatitis B vaccines are associated in patients on maintenance hemodialysis: a single-centre experience in Belgium
por: Van Regemorter, Elliott, et al.
Publicado: (2021)

Vancomycin dosing in patients undergoing maintenance hemodialysis
por: Rymarz, Aleksandra, et al.
Publicado: (2014)

Humoral response to vaccination against SARS-CoV-2 in patients undergoing dialysis
por: Lee, Yoo Jin, et al.
Publicado: (2022)

Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
por: Hernández-Porto, Miriam, et al.
Publicado: (2022)

Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
por: Anft, Moritz, et al.
Publicado: (2022)

Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients
por: Wand, Ori, et al.
Publicado: (2022)

Impaired humoral immune response to hepatitis B vaccine in patients on maintenance hemodialysis
por: Mahallawi, Waleed H., et al.
Publicado: (2023)

Kinetics of the humoral response 1-year following vaccination with BNT162b2 SARS-CoV-2 vaccine among maintenance hemodialysis patients
por: Wand, Ori, et al.
Publicado: (2022)

Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
por: Cinkilic, Okan, et al.
Publicado: (2022)

Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
por: Arteaga-Müller, Giovanna Yazmin, et al.
Publicado: (2021)

Humoral Response to SARS-CoV-2 in Hemodialysis Patients
por: Steers, Nicholas J.
Publicado: (2021)

Humoral Response to Hepatitis B and COVID-19 Vaccine among Maintenance Hemodialysis Patients
por: Nacasch, Naomi, et al.
Publicado: (2022)

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination
por: Gonzalez-Perez, Maria, et al.
Publicado: (2023)

Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination
por: Zhao, Wen-Man, et al.
Publicado: (2022)

The Humoral Response to SARS-CoV-2 Vaccine in Hemodialysis Patients Is Correlated with Nutritional Status
por: Jacobson-Naftali, Merav, et al.
Publicado: (2023)

Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost
por: Davidovic, Tamara, et al.
Publicado: (2021)

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone
por: Cheng, Chongsheng, et al.
Publicado: (2022)

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022)

Longevity and Clinical Effectiveness of the Humoral and Cellular Responses to SARS-CoV-2 Vaccination in Hemodialysis Patients
por: De Vriese, An S., et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients
por: Kwiatkowska, Ewa, et al.
Publicado: (2022)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis
por: Espi, Maxime, et al.
Publicado: (2021)

The Waxing, Waning, and Predictors of Humoral Responses to Vector-Based SARS-CoV-2 Vaccine in Hemodialysis Patients
por: Fu, Chung-Ming, et al.
Publicado: (2022)

A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse
por: Westhoff, Timm H., et al.
Publicado: (2021)

Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
por: Chen, Zhiwei, et al.
Publicado: (2022)

Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
por: Attias, Philippe, et al.
Publicado: (2021)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

Prevalence of fatigue during the SARS-CoV-2 pandemic in patients and workers of a hemodialysis unit
por: Hérnandez García, Elena, et al.
Publicado: (2022)

Association of malnutrition with SARS-CoV-2 vaccine response in patients undergoing hemodialysis
por: Lin, Ting-Yun, et al.
Publicado: (2022)

Humoral response after SARS-CoV-2 booster vaccination in haemodialysis patients with and without prior infection
por: Füessl, Louise, et al.
Publicado: (2022)

Long‐term effects of homologous and heterologous SARS‐CoV‐2 vaccination on humoral and cellular immune responses
por: Hollstein, Moritz M., et al.
Publicado: (2022)

Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study
por: Mirioglu, Safak, et al.
Publicado: (2023)

Answering the call to action: rapid implementation of an in-center hemodialysis SARS-CoV-2 vaccination program
por: Gleeson, Sarah, et al.
Publicado: (2021)

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Significance of Adipose Tissue Maintenance in Patients Undergoing Hemodialysis
por: Okuno, Senji
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mgu02uihv7ukibjvunqf4lan5r